MelmarT Melanoma Margins Trial Investigating 1cm v 2cm Wide Excision Margins for Primary Cutaneous Melanoma

NAActive, not recruitingINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

January 3, 2015

Primary Completion Date

August 4, 2016

Study Completion Date

August 5, 2026

Conditions
Cutaneous Melanoma by AJCC V7 Stage
Interventions
PROCEDURE

Wide Local Excision = 1cm Margin

"A wide local excision involves removing an extra safety margin of healthy skin surrounding the original melanoma site to ensure that any remaining scattered melanoma tumour cells are removed that may have been left behind after the first initial biopsy/surgery."

PROCEDURE

Wide Local Excision = 2cm Margin

"A wide local excision involves removing an extra safety margin of healthy skin surrounding the original melanoma site to ensure that any remaining scattered melanoma tumour cells are removed that may have been left behind after the first initial biopsy/surgery."

Trial Locations (20)

2060

Melanoma Institute Australia - Poche Centre, North Sydney

3002

Peter MacCallum Cancer Centre Division of Cancer Surgery, Melbourne

3004

Alfred Hospital, Melbourne

4225

Gold Coast Melanom Clinic, Coolangatta

19107

Thomas Jefferson University Hospital, Philadelphia

Unknown

Sunnybrook Health Sciences Centre, Toronto

Sahlgrenska University Hospital, Gothenburg

Imperial College Healthcare NHS Trust, London

HU16 5JQ

Hull and East Yorkshire Hospitals NHS Trust, Hull

SE1 7EH

Guy's and St Thomas' Hospital NHS Trust, London

M20 4BX

The Christie NHS Foundation Trust, Manchester

CM1 7ET

Mid Essex Hospital Services NHS Trust, Broomfield

L35 5DR

St Helens & Knowsley NHS Trust, St Helens

OX3 9DU

Oxford University Hospitals NHS Trust, Headington

BS10 5NB

North Bristol NHS Trust, Bristol

CB2 0QQ

Cambridge University Hospitals NHS Foundation Trust, Cambridge

EX2 5DW

Royal Devon and Exeter NHS Foundation Trust, Exeter

LS9 7TF

St. James University Hospital, Leeds

NW3 2QG

Royal Free London NHS Foundation Trust, London

NR4 7UY

Norfolk and Norwich University Hospital, Norwich

All Listed Sponsors
collaborator

Peter MacCallum Cancer Centre, Australia

OTHER

collaborator

Norfolk and Norwich University Hospitals NHS Foundation Trust

OTHER

lead

Melanoma and Skin Cancer Trials Limited

OTHER

NCT02385214 - MelmarT Melanoma Margins Trial Investigating 1cm v 2cm Wide Excision Margins for Primary Cutaneous Melanoma | Biotech Hunter | Biotech Hunter